Literature DB >> 27237102

Gelatinase and Vulnerability of Atherosclerotic Plaque.

Masaaki Hoshiga1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27237102      PMCID： PMC7399262          DOI： 10.5551/jat.ED048

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  10 in total

Review 1.  Requiem for the 'vulnerable plaque'.

Authors:  Peter Libby; Gerard Pasterkamp
Journal:  Eur Heart J       Date:  2015-07-22       Impact factor: 29.983

Review 2.  Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation.

Authors:  Andrew C Newby
Journal:  Matrix Biol       Date:  2015-01-28       Impact factor: 11.583

3.  Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.

Authors:  Joost P G Sluijter; Wilco P C Pulskens; Arjan H Schoneveld; Evelyn Velema; Chaylendra F Strijder; Frans Moll; Jean-Paul de Vries; Jan Verheijen; Roeland Hanemaaijer; Dominique P V de Kleijn; Gerard Pasterkamp
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

4.  Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma.

Authors:  Paula Clancy; Sai-Wang Seto; Simon A Koblar; Jonathan Golledge
Journal:  Atherosclerosis       Date:  2013-06-01       Impact factor: 5.162

Review 5.  Matrix metalloproteinase inhibition therapy for vascular diseases.

Authors:  Andrew C Newby
Journal:  Vascul Pharmacol       Date:  2012-02-01       Impact factor: 5.773

Review 6.  Collagens in the progression and complications of atherosclerosis.

Authors:  Eser Adiguzel; Pamela J Ahmad; Christopher Franco; Michelle P Bendeck
Journal:  Vasc Med       Date:  2009-02       Impact factor: 3.239

7.  Plaque-stabilizing effect of angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker in a rabbit plaque model.

Authors:  Junko Hotchi; Masaaki Hoshiga; Yoshihiro Takeda; Takahito Yuki; Tomohiro Fujisaka; Tadashi Ishihara; Toshiaki Hanafusa
Journal:  J Atheroscler Thromb       Date:  2012-11-15       Impact factor: 4.928

Review 8.  Matrix metalloproteases as a pharmacological target in cardiovascular diseases.

Authors:  E Hopps; G Caimi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015       Impact factor: 3.507

9.  Rabbit plaque models closely resembling lesions in human coronary artery disease.

Authors:  Taichi Okabe; Masaaki Hoshiga; Nobuyuki Negoro; Takahiro Nakakoji; Kumiko Arishiro; Tadashi Ishihara; Hikaru Ueno; Toshiaki Hanafusa
Journal:  Int J Cardiol       Date:  2009-11-06       Impact factor: 4.164

10.  Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase Regulation in Human Carotid Atheroma in vitro.

Authors:  Paula Clancy; Simon Koblar; Jonathan Golledge
Journal:  J Atheroscler Thromb       Date:  2016-03-05       Impact factor: 4.928
  10 in total
  1 in total

1.  Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.

Authors:  Andrei Maiseyeu; Lin Di; Anastasia Ravodina; Alma Barajas-Espinosa; Atsushi Sakamoto; Alice Chaplin; Jixin Zhong; Huiyun Gao; Matthew Mignery; Navneet Narula; Aloke V Finn; Sanjay Rajagopalan
Journal:  Theranostics       Date:  2022-03-06       Impact factor: 11.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.